Thomas Catinazzo Relay Therapeutics, Inc. (RLAY) insider trading activity

RLAY Quotes by TradingView

Thomas Catinazzo is Chief Financial Officer of Relay Therapeutics, Inc.. Currently has a direct ownership of 319,650 shares of RLAY, which is worth approximately $2.43 Million. The most recent transaction as insider was on Mar 24, 2022, when has been sold 13,286 shares (Common Stock) at a price of $4.12 per share, resulting in proceeds of $54,738. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K
5.93% 3M change
118.73% 12M change
Total Value Held $2.43 Million

Thomas Catinazzo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2022
BUY
Exercise of conversion of derivative security
$54,738 $4.12 p/Share
13,286 Added 16.44%
67,545 Common Stock
Jan 27 2022
BUY
Grant, award, or other acquisition
-
39,270 Added 41.99%
54,259 Common Stock
Dec 27 2021
SELL
Open market or private sale
$9,764 $33.1 p/Share
295 Reduced 1.93%
14,989 Common Stock
Nov 15 2021
SELL
Open market or private sale
$796,500 $35.4 p/Share
22,500 Reduced 59.55%
15,284 Common Stock
Nov 15 2021
BUY
Exercise of conversion of derivative security
$92,700 $4.12 p/Share
22,500 Added 37.32%
37,784 Common Stock
Sep 27 2021
SELL
Open market or private sale
$10,803 $36.87 p/Share
293 Reduced 1.88%
15,284 Common Stock
Sep 13 2021
SELL
Open market or private sale
$787,500 $35.0 p/Share
22,500 Reduced 59.09%
15,577 Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
$92,700 $4.12 p/Share
22,500 Added 37.14%
38,077 Common Stock
Jun 28 2021
SELL
Open market or private sale
$10,492 $35.81 p/Share
293 Reduced 1.85%
15,577 Common Stock
Jun 07 2021
SELL
Open market or private sale
$787,500 $35.0 p/Share
22,500 Reduced 58.64%
15,870 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$92,700 $4.12 p/Share
22,500 Added 36.96%
38,370 Common Stock
Mar 30 2021
SELL
Open market or private sale
$787,500 $35.0 p/Share
22,500 Reduced 100.0%
0 Common Stock
Mar 30 2021
BUY
Exercise of conversion of derivative security
$92,700 $4.12 p/Share
22,500 Added 50.0%
22,500 Common Stock
Mar 26 2021
BUY
Grant, award, or other acquisition
-
15,870 Added 50.0%
15,870 Common Stock
TC

Thomas Catinazzo

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on RLAY

Follow Relay Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

News

Receive news related to Relay Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RLAY